Tandem Diabetes Care, Inc.
TNDM
$22.72
-$0.41-1.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.96% | 4.54% | 7.93% | 17.87% | 25.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.96% | 4.54% | 7.93% | 17.87% | 25.84% |
| Cost of Revenue | -3.63% | -1.38% | 4.02% | 9.80% | 17.23% |
| Gross Profit | 10.82% | 9.95% | 11.53% | 26.00% | 34.79% |
| SG&A Expenses | 4.60% | 8.07% | 11.36% | 14.79% | 19.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.94% | 1.27% | 5.15% | 10.50% | 16.82% |
| Operating Income | 53.78% | 33.59% | 21.19% | 35.89% | 34.10% |
| Income Before Tax | 69.86% | 43.78% | -117.99% | -66.35% | -54.14% |
| Income Tax Expenses | -23.79% | -137.23% | 6.81% | -143.84% | -41.27% |
| Earnings from Continuing Operations | 69.18% | 48.58% | -113.18% | -60.41% | -50.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.18% | 48.58% | -113.18% | -60.41% | -50.52% |
| EBIT | 53.78% | 33.59% | 21.19% | 35.89% | 34.10% |
| EBITDA | 67.02% | 42.45% | 26.74% | 41.68% | 39.26% |
| EPS Basic | 70.03% | 49.66% | -108.59% | -57.02% | -47.67% |
| Normalized Basic EPS | 39.86% | 12.81% | -2.66% | 25.04% | 29.06% |
| EPS Diluted | 70.03% | 49.66% | -108.59% | -57.02% | -47.67% |
| Normalized Diluted EPS | 39.87% | 12.82% | -2.65% | 25.03% | 29.05% |
| Average Basic Shares Outstanding | 3.07% | 3.13% | 2.80% | 2.23% | 1.58% |
| Average Diluted Shares Outstanding | 2.99% | 3.05% | 2.71% | 2.31% | 1.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |